What the FDA review means for you
KPV legal status: no approval and no final FDA vote
FDA advisers met in 2026. Staff opposed pharmacy use of KPV, and FDA had not posted a final decision.
KPV still lacks drug approval and routine pharmacy access
Researchers made KPV to study the swelling effect of a body hormone. KPV was not made or approved as a medicine, which is the clearest legal answer for you.
FDA advisers met in July 2026 to ask whether pharmacies could make medicines from raw KPV [18]. FDA staff advised keeping raw KPV off the allowed ingredient list. The person had already withdrawn the request, but the meeting still occurred. FDA has posted no final vote or new rule from the 2026 meeting. The cited rules do not show that a pharmacy may routinely make KPV. Nothing on this page offers KPV for sale or supply.
FDA staff opposed both forms of KPV in July 2026
FDA’s pharmacy advisers met in July 2026 to consider raw KPV for pharmacy-made medicines [18]. They examined forms called free base and acetate, two ways chemists prepare KPV [18]. Neither form is an approved drug; the agenda also named BPC-157 and TB-500, two other study substances that don’t alter KPV’s status. FDA staff advised keeping both KPV forms off the allowed list. The person who sought a listing had already withdrawn the request.
What changed in 2026? The meeting took place, but FDA had posted no final vote [18]. The advisers give advice, while FDA makes the final rule later [17]. In 2026, KPV still had no drug approval or confirmed place on the list [18]. The meeting did not give you a new way to get KPV.

KPV is not approved, and pharmacies lack a legal way to make it
A body hormone contains the three parts called KPV, and KPV lacks FDA drug approval [16][17]. KPV has never been given to a person in a published trial [13]. When a pharmacy makes a drug to order, federal law offers three tests for its raw ingredient. It may have an official written quality standard [17]. That standard tells a pharmacist how to check the ingredient, but it does not prove safety or benefit. An approved medicine may already use the ingredient. A place on FDA’s allowed list is the third legal test.
FDA advisers reviewed KPV at the 2026 meeting [18]. Staff opposed adding it to the list; FDA had posted no final ruling, and KPV still lacked drug approval [17][18]. The meeting gave KPV no new legal standing [18]. No cited rule shows that a pharmacy may routinely make it for you.
One pharmacy fills a personal order; another supplies clinics
Federal law covers two ways pharmacies make drugs. A local pharmacy may fill a valid prescription for one named person [17]. Another kind may register with FDA and make larger batches for clinics under added checks [17]. This work is called compounding: making a medicine for a person or clinic when a standard product does not fit.
The raw ingredient must also pass a legal test. It may have an official written quality standard [17]. An approved drug may already contain it, or FDA may put it on the allowed list. People can ask FDA to consider a new raw ingredient, and years ago, FDA placed open requests into numbered groups while it reviewed them. On January 7, 2025, FDA stopped using those groups for new requests [17][19]. That paperwork change did not approve KPV. A drug maker also has not completed FDA’s full review for KPV as a finished medicine [16][17].
A prescription does not make raw KPV lawful
How does a pharmacy-made medicine usually reach you? A licensed doctor first decides whether it fits your care [17]. If the ingredient is lawful, the doctor writes a prescription in your name, and a state-licensed pharmacy may fill it. Another FDA-registered kind may make larger batches for clinics under tighter checks [17].
A video visit does not change which raw ingredients the law allows [17]. The doctor still needs a real medical reason and must follow the same prescription rules. For KPV, two facts control the answer: no drug approval and no confirmed place on FDA’s allowed list [17][18]. A prescription alone cannot change those facts [17].
We name no pharmacy, clinic, video company, or seller, and this page gives no way around the law. It gives the federal answer but can’t settle your personal medical or legal case. Nothing here is for sale.
Your state and planned use can add other KPV rules
KPV still lacks FDA drug approval [16][17]. FDA advisers reviewed it at the July 23-24, 2026 meeting [18]. Staff urged FDA to keep KPV off the pharmacy list, and FDA had posted no final ruling. Your state and planned use may add other rules. This page covers federal pharmacy law. It can’t give you legal advice.
Current federal rules do not show routine pharmacy use of KPV
The federal ingredient list does not include KPV. It also lacks an official written quality standard, and no approved drug contains KPV [17][18]. A prescription cannot make the raw ingredient lawful by itself [17]. FDA advisers reviewed KPV in July 2026, and staff opposed adding it. FDA had posted no later final rule [18].
The July review did not approve either form of KPV
KPV has never received FDA drug approval [16][18]. Advisers reviewed its free base and acetate forms at the July 2026 meeting. FDA staff said neither form belonged on the pharmacy list. The meeting agenda did not change the rule. FDA had posted no final vote or listing [17][18].